Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and more.

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke ...

As a result of being a caregiver for her cousin, columnist Sylvia Amuta says she's now more caring, compassionate, and kind ...

A month after a sickle cell pain crisis, columnist Dunstan Nicol-Wilson is learning how to trust his body again, which isn't easy.

The first healthy volunteer has been dosed in a Phase 1 study of Cellarity's novel globin-switching therapy CLY-124 for ...

Higher pain scores upon discharge from the emergency department may predict hospitalization in adolescents with SCD, a study ...

Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a study shows.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 trial.

Columnist Mary Shaniqua shares the benefits of attending the European Hematology Association's 2025 Congress as a sickle cell patient.